Back to resultsEvaluation of Patients With Known or Suspected Heart Disease
Primary Purpose
Peripheral Artery Disease, Coronary Disease, Diabetes and Heart Failure
Status
Completed
Phase
Locations
United States
Study Type
Observational
Intervention
Sponsored by
About this trial
This is an observational trial for Peripheral Artery Disease focused on measuring Cardiac Diagnosis, Chest Pain, Hypertrophic Cardiomyopathy, Coronary Artery Disease, Microvascular Angina, Cardiac Investigation, Follow-up, Heart Disease
Eligibility Criteria
INCLUSION CRITERIA: The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol: Coronary artery disease with angina or inducible myocardial ischemia as determined by noninvasive testing. Cardiomyopathies including congestive phenotypes. Peripheral artery disease with intermittent claudication or limb-threatening ischemia. Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy. Upper extremity peripheral artery disease. Diabetes with heart failure. Pulmonary hypertension. EXCLUSION CRITERIA: Pregnancy, for those patients who require catheterization-based diagnostics. Inability to provide informed consent.
Sites / Locations
- Suburban Hospital
- National Institutes of Health Clinical Center, 9000 Rockville Pike
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00001313
First Posted
November 3, 1999
Last Updated
June 30, 2017
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
1. Study Identification
Unique Protocol Identification Number
NCT00001313
Brief Title
Evaluation of Patients With Known or Suspected Heart Disease
Official Title
Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Study Type
Observational
2. Study Status
Record Verification Date
January 6, 2009
Overall Recruitment Status
Completed
Study Start Date
May 10, 1992 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
January 6, 2009 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
4. Oversight
5. Study Description
Brief Summary
In this study researchers will admit and evaluate patients with known or suspected heart disease referred to the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI).
Patients participating in this study will undergo a general medical evaluation, including blood tests, urine, examination, chest x-ray and electrocardiogram (EKG). In addition, patients may be asked to have an echocardiogram (ultrasound scan of the heart) and to perform an exercise stress test.
These tests are designed to assess the types and causes of patient's heart diseases and to determine if they can participate in other, specific research studies.
Detailed Description
The principal mission of the NIH is the conduct of research that elucidates biological mechanisms, pathogenesis, and treatment of disease. Patients with known or suspected cardiovascular diseases are referred to NHLBI cardiologists for consideration of participation in clinical research protocols. However, eligibility for participation is often uncertain from referral information or even after an outpatient evaluation. The purpose of this protocol is to permit inpatient evaluation of patients for whom participation in clinical research protocols is under consideration in order to determine protocol eligibility by means of conventional laboratory and cardiovascular testing.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Peripheral Artery Disease, Coronary Disease, Diabetes and Heart Failure, Dilated Cardiomyopathy, Heart Failure, Renal Artery Stenosis, Pulmonary Hypertension
Keywords
Cardiac Diagnosis, Chest Pain, Hypertrophic Cardiomyopathy, Coronary Artery Disease, Microvascular Angina, Cardiac Investigation, Follow-up, Heart Disease
7. Study Design
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
INCLUSION CRITERIA:
The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol:
Coronary artery disease with angina or inducible myocardial ischemia as determined by noninvasive testing.
Cardiomyopathies including congestive phenotypes.
Peripheral artery disease with intermittent claudication or limb-threatening ischemia.
Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy.
Upper extremity peripheral artery disease.
Diabetes with heart failure.
Pulmonary hypertension.
EXCLUSION CRITERIA:
Pregnancy, for those patients who require catheterization-based diagnostics.
Inability to provide informed consent.
Facility Information:
Facility Name
Suburban Hospital
City
Bethesda
State/Province
Maryland
ZIP/Postal Code
20814
Country
United States
Facility Name
National Institutes of Health Clinical Center, 9000 Rockville Pike
City
Bethesda
State/Province
Maryland
ZIP/Postal Code
20892
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Evaluation of Patients With Known or Suspected Heart Disease
We'll reach out to this number within 24 hrs